Literature DB >> 23277210

Bilateral retinoblastoma: clinical presentation, management and treatment.

Francesco Pichi1, Andrea Lembo, Mariacarla De Luca, Theodora Hadjistilianou, Paolo Nucci.   

Abstract

Management of retinoblastoma (Rb), the most common intraocular malignant tumor in childhood, is tailored to each individual case and based on the overall situation. We present a case of bilateral Rbs in a 4-month-old girl, referred to our center for bilateral leukocoria. In the right eye, the optic disc was partially visible, and three large foci of retinoblastoma were noted adjective in the vitreous cavity with satellite retinal detachment. The macula was obscured by the tumors. The tumor was therefore classified as group D (International classification of retinoblastoma), and thus underwent intravenous chemotherapy with the standard three-agent protocol of ifosfamide, carboplatin and etoposide (ICE protocol) delivered monthly for six cycles, regressing with a type I calcified pattern. The left eye presented three multifocal yellow-white retinal masses, with a total retinal detachment, and secondary glaucoma. The lesions were classified as group E and, therefore, taking the results obtained by Shields et al. in group E tumors into consideration, underwent enucleation. This case clearly shows that this cancer is curable if detected at a stage in which it is still contained within the retina, subretinal space or vitreous, and that the management of Rb relies on an experienced team of ocular oncologists, pediatricians and pediatric ophthalmologists working together for the single goal of saving the child's life.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23277210     DOI: 10.1007/s10792-012-9703-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  24 in total

1.  Changing management of retinoblastoma.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 4.207

Review 2.  Basic understanding of current classification and management of retinoblastoma.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Curr Opin Ophthalmol       Date:  2006-06       Impact factor: 3.761

Review 3.  Intraocular retinoblastoma: the case for a new group classification.

Authors:  A Linn Murphree
Journal:  Ophthalmol Clin North Am       Date:  2005-03

4.  Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.

Authors:  Carol L Shields; Santosh G Honavar; Anna T Meadows; Jerry A Shields; Hakan Demirci; Arun Singh; Debra L Friedman; Thomas John Naduvilath
Journal:  Am J Ophthalmol       Date:  2002-05       Impact factor: 5.258

5.  Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.

Authors:  M S Uusitalo; K R Van Quill; I U Scott; K K Matthay; T G Murray; J M O'Brien
Journal:  Arch Ophthalmol       Date:  2001-01

6.  Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).

Authors:  C L Shields; A T Meadows; J A Shields; C Carvalho; A F Smith
Journal:  Arch Ophthalmol       Date:  2001-09

7.  Postenucleation adjuvant therapy in high-risk retinoblastoma.

Authors:  Santosh G Honavar; Arun D Singh; Carol L Shields; Anna T Meadows; Hakan Demirci; Jacqueline Cater; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2002-07

8.  Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.

Authors:  Carol L Shields; Arman Mashayekhi; Jacqueline Cater; Abdallah Shelil; Anna T Meadows; Jerry A Shields
Journal:  Am J Ophthalmol       Date:  2004-09       Impact factor: 5.258

9.  Standard enucleation with aluminium oxide implant (bioceramic) covered with patient's sclera.

Authors:  Gian Luigi Zigiotti; Sonia Cavarretta; Mariachiara Morara; Sang Min Nam; Stefano Ranno; Francesco Pichi; Andrea Lembo; Stefano Lupo; Paolo Nucci; Alessandro Meduri
Journal:  ScientificWorldJournal       Date:  2012-04-30

10.  Clinical variations of trilateral retinoblastoma: a report of 13 cases.

Authors:  P De Potter; C L Shields; J A Shields
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1994 Jan-Feb       Impact factor: 1.402

View more
  5 in total

1.  Two masquerade presentations of retinoblastoma.

Authors:  Andrea Lembo; Francesco Pichi; Elisabetta Santangelo; Paola Carrai; Theodora Hadjistilianou; Massimiliano Serafino; Paolo Nucci
Journal:  Int Ophthalmol       Date:  2015-10-08       Impact factor: 2.031

2.  Massive anterior chamber involvement after intra-arterial chemotherapy for retinoblastoma: ultrasound biomicroscopy and histopathology.

Authors:  Sonia De Francesco; Francesco Pichi; Andrea Lembo; Domenico Mastrangelo; Anna Paradiso; Mariacarla De Luca; Paolo Toti; Paolo Nucci; Theodora Hadjistilianou
Journal:  Int Ophthalmol       Date:  2014-01-30       Impact factor: 2.031

3.  Diffuse infiltrating retinoblastoma coexisting with ocular toxoplasmosis.

Authors:  Fariba Ghassemi; Hadi Ghadimi; Fahimeh Asadi Amoli; Mohammad Riazi Esfahani; Vida Tavakoli; Ghassemi Fariba
Journal:  Int Ophthalmol       Date:  2013-03-16       Impact factor: 2.031

4.  Exploring the Mechanism of Curcumin on Retinoblastoma Based on Network Pharmacology and Molecular Docking.

Authors:  Chengfu Wu; Wenli Zheng; Jifa Zhang; Xingping He
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-19       Impact factor: 2.650

5.  Recurrent Sporadic Bilateral Retinoblastoma in a Child with 13q Deletion Syndrome.

Authors:  Laila Tul Qadar; Syed Ali Shazif Baqari; Hira Maab; Sarrah Ali Asghar; Muhammad Saad Hafeez
Journal:  Cureus       Date:  2020-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.